NFATC1
Nuclear factor of activated T-cells, cytoplasmic 1
Also known as: NF-ATC, NFAC1_HUMAN, NFAT2, NFATc
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95644
- Gene
- NFATC1
- Ensembl
- ENSG00000131196
- Chromosome
- 18
- Canonical length
- 943 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The product of this gene is a component of the nuclear factor of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation, and an inducible nuclear component. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. The product of this gene is an inducible nuclear component. It functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Different isoforms of this protein may regulate inducible expression of different cytokine genes. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
943 residues, UniProt reviewed canonical sequence.
>O95644|NFATC1
1 MPSTSFPVPS KFPLGPAAAV FGRGETLGPA PRAGGTMKSA EEEHYGYASS NVSPALPLPT
61 AHSTLPAPCH NLQTSTPGII PPADHPSGYG AALDGGPAGY FLSSGHTRPD GAPALESPRI
121 EITSCLGLYH NNNQFFHDVE VEDVLPSSKR SPSTATLSLP SLEAYRDPSC LSPASSLSSR
181 SCNSEASSYE SNYSYPYASP QTSPWQSPCV SPKTTDPEEG FPRGLGACTL LGSPRHSPST
241 SPRASVTEES WLGARSSRPA SPCNKRKYSL NGRQPPYSPH HSPTPSPHGS PRVSVTDDSW
301 LGNTTQYTSS AIVAAINALT TDSSLDLGDG VPVKSRKTTL EQPPSVALKV EPVGEDLGSP
361 PPPADFAPED YSSFQHIRKG GFCDQYLAVP QHPYQWAKPK PLSPTSYMSP TLPALDWQLP
421 SHSGPYELRI EVQPKSHHRA HYETEGSRGA VKASAGGHPI VQLHGYLENE PLMLQLFIGT
481 ADDRLLRPHA FYQVHRITGK TVSTTSHEAI LSNTKVLEIP LLPENSMRAV IDCAGILKLR
541 NSDIELRKGE TDIGRKNTRV RLVFRVHVPQ PSGRTLSLQV ASNPIECSQR SAQELPLVEK
601 QSTDSYPVVG GKKMVLSGHN FLQDSKVIFV EKAPDGHHVW EMEAKTDRDL CKPNSLVVEI
661 PPFRNQRITS PVHVSFYVCN GKRKRSQYQR FTYLPANVPI IKTEPTDDYE PAPTCGPVSQ
721 GLSPLPRPYY SQQLAMPPDP SSCLVAGFPP CPQRSTLMPA APGVSPKLHD LSPAAYTKGV
781 ASPGHCHLGL PQPAGEAPAV QDVPRPVATH PGSPGQPPPA LLPQQVSAPP SSSCPPGLEH
841 SLCPSSPSPP LPPATQEPTC LQPCSPACPP ATGRPQHLPS TVRRDESPTA GPRLLPEVHE
901 DGSPNLAPIP VTVKREPEEL DQLYLDDVNE IIRNDLSSTS THSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NFATC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 34 nTPM
- skeletal muscle: 31 nTPM
- lymph node: 20 nTPM
- spleen: 18 nTPM
- heart muscle: 15 nTPM
- blood vessel: 13 nTPM
Single-cell type
- salivary myoepithelial cells: 288 nCPM
- lymphatic endothelial cells: 174 nCPM
- epididymal basal cells: 141 nCPM
- salivary basal cells: 129 nCPM
- b-cells: 125 nCPM
- innate lymphoid cells: 122 nCPM
Immune cell
- non-classical monocyte: 14 nTPM
- naive B-cell: 10 nTPM
- intermediate monocyte: 9.1 nTPM
- memory B-cell: 7.6 nTPM
- eosinophil: 7.5 nTPM
- memory CD4 T-cell: 6.2 nTPM
Brain region
- choroid plexus: 57 nTPM
- medulla oblongata: 17 nTPM
- spinal cord: 15 nTPM
- midbrain: 15 nTPM
- thalamus: 15 nTPM
- pons: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.16
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aortic valve morphogenesis
- calcineurin-NFAT signaling cascade
- intracellular signal transduction
- negative regulation of inflammatory response
- negative regulation of vascular associated smooth muscle cell differentiation
- negative regulation of Wnt signaling pathway
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- pulmonary valve morphogenesis
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- FK506 binding
- mitogen-activated protein kinase p38 binding
- protein phosphatase 2B binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- IPT domain
- Nuclear factor of activated T cells (NFAT)
- p53-like transcription factor, DNA-binding domain superfamily
- Rel homology domain, DNA-binding domain
- Immunoglobulin-like fold
- Immunoglobulin E-set
- Rel homology dimerisation domain
- Rel homology domain (RHD), DNA-binding domain superfamily
- Rel homology DNA-binding domain
- Rel homology dimerisation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NFATC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NFATC1 as an antibody target. Whether an autoantibody or antibody against NFATC1 could matter depends on whether native NFATC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NFATC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NFATC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...